Other Viruses Citation List: March 29 - April 11, 2013
Hepatitis B Virus
1. Anti-HBV Active Constituents from Piper longum. Jiang, Z.Y., W.F. Liu, X.M. Zhang, J. Luo, Y.B. Ma, and J.J. Chen. Bioorganic & Medicinal Chemistry Letters, 2013. 23(7): p. 2123-2127; PMID[23434420].
[PubMed] OV_0329-041113.
2. Anti-Hepatitis B Virus and Anti-cancer Activities of Novel Isoflavone Analogs. Zhang, Y., H. Zhong, Z. Lv, M. Zhang, T. Zhang, Q. Li, and K. Li. European Journal of Medicinal Chemistry, 2013. 62: p. 158-167; PMID[23353737].
[PubMed] OV_0329-041113.
Hepatitis C Virus
3. Synthesis and Evaluation of Non-dimeric HCV NS5A Inhibitors. Amblard, F., H. Zhang, L. Zhou, J. Shi, D.R. Bobeck, J.H. Nettles, S. Chavre, T.R. McBrayer, P. Tharnish, T. Whitaker, S.J. Coats, and R.F. Schinazi. Bioorganic & Medicinal Chemistry Letters, 2013. 23(7): p. 2031-2034; PMID[23466233]. [PubMed] OV_0329-041113.
4. Synthesis and Evaluation against Hepatitis C Virus of 7-Deaza Analogues of 2'-C-Methyl-6-O-methyl guanosine Nucleoside and L-Alanine ester phosphoramidates. Bourdin, C., C. McGuigan, A. Brancale, S. Chamberlain, J. Vernachio, J. Hutchins, E. Gorovits, A. Kolykhalov, J. Muhammad, J. Patti, G. Henson, B. Bleiman, K.D. Bryant, B. Ganguly, D. Hunley, A. Obikhod, C.R. Walters, J. Wang, C.V. Ramamurty, S.K. Battina, and C. Srivinas Rao. Bioorganic & Medicinal Chemistry Letters, 2013. 23(7): p. 2260-2264; PMID[23453067].
[PubMed] OV_0329-041113.
5. Achiral Pyrazinone-based Inhibitors of the Hepatitis C Virus NS3 Protease and Drug-Resistant Variants with Elongated Substituents Directed toward the S2 Pocket. Gising, J., A.K. Belfrage, H. Alogheli, A. Ehrenberg, E. Akerblom, R. Svensson, P. Artursson, A. Karlen, U.H. Danielson, M. Larhed, and A. Sandstrom. Journal of Medicinal Chemistry, 2013. [Epub ahead of print]; PMID[23517538].
[PubMed] OV_0329-041113.
6. Hepatitis C Replication Inhibitors That Target the Viral NS4B Protein. Miller, J.F., P.Y. Chong, J.B. Shotwell, J.G. Catalano, V.W. Tai, J.M. Fang, A.L. Banka, C.D. Roberts, M.K. Youngman, H. Zhang, Z. Xiong, A. Mathis, J.J. Pouliot, R.K. Hamatake, D.J. Price, J.W. Seal, L.L. Stroup, K.L. Creech, L.H. Carballo, D. Todd, A. Spaltenstein, S.M. Furst, Z. Hong, and A.J. Peat. Journal of Medicinal Chemistry, 2013. [Epub ahead of print]; PMID[23544424].
[PubMed] OV_0329-041113.
7. NS5A Inhibitors in the Treatment of Hepatitis C. Pawlotsky, J.M. Journal of Hepatology, 2013. [Epub ahead of print]; PMID[23567084].
[PubMed] OV_0329-041113.
8. IL-28b (IFN-lambda3) and IFN-alpha Synergistically Inhibit HCV Replication. Shindo, H., S. Maekawa, K. Komase, M. Miura, M. Kadokura, R. Sueki, N. Komatsu, K. Shindo, F. Amemiya, Y. Nakayama, T. Inoue, M. Sakamoto, A. Yamashita, K. Moriishi, and N. Enomoto. Journal of Viral Hepatitis, 2013. 20(4): p. 281-289; PMID[23490373].
[PubMed] OV_0329-041113.
Citations from the ISI Web of Knowledge Listings for O.V.
9. Telaprevir: Protease Inhibitor Drug Against Hepatitis C. Bourel-Bonnet, L. and E. Kellenberger. Virologie, 2013. 17(1): p. 3-5; ISI[000315568800001].
[WOS] OV_0329-041113.
10. 5-(Perylen-3-yl) ethynyl-arabino-uridine (AUY11), an Arabino-based Rigid Amphipathic Fusion Inhibitor, Targets Virion Envelope Lipids to Inhibit Fusion of Influenza Virus, Hepatitis C Virus, and Other Enveloped Viruses. Colpitts, C.C., A.V. Ustinov, R.F. Epand, R.M. Epand, V.A. Korshun, and L.M. Schang. Journal of Virology, 2013. 87(7): p. 3640-3654; ISI[000315957100003].
[WOS] OV_0329-041113.
11. Macromolecular Prodrugs of Ribavirin Combat Side Effects and Toxicity with No Loss of Activity of the Drug. Kryger, M.B.L., B.M. Wohl, A.A.A. Smith, and A.N. Zelikin. Chemical Communications, 2013. 49(26): p. 2643-2645; ISI[000315648400014].
[WOS] OV_0329-041113.
12. Dioscin's Antiviral Effect in Vitro. Liu, C.H., Y. Wang, C.C. Wu, R.J. Pei, J.H. Song, S.Y. Chen, and X.W. Chen. Virus Research, 2013. 172(1-2): p. 9-14; ISI[000315756700002].
[WOS] OV_0329-041113.
13. The Postbinding Activity of Scavenger Receptor Class B Type I Mediates Initiation of Hepatitis C Virus Infection and Viral Dissemination. Zahid, M.N., M. Turek, F. Xiao, V.L.D. Thi, M. Guerin, I. Fofana, P. Bachellier, J. Thompson, L. Delang, J. Neyts, D. Bankwitz, T. Pietschmann, M. Dreux, F.L. Cosset, F. Grunert, T.F. Baumert, and M.B. Zeisel. Hepatology, 2013. 57(2): p. 492-504; ISI[000315643400010].
[WOS] OV_0329-041113.